This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (17) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Appell, K. C. Articles by Chelsky, D. Search for Related Content PubMed Articles by Appell, K. C. Articles by Chelsky, D. Social Bookmarking                         What's this?

Biological Characterization of Neurokinin Antagonists Discovered Through Screening of a Combinatorial Library

Pharmacopeia, Inc., 101 College Rd. East, Princeton, NJ 08540

Thomas D.Y. Chung

DuPont Merck Pharmaceutical, DuPont Experimental Station, Wilmington, DE 19880

Kelli J. Solly

Pharmacopeia, Inc., 101 College Rd. East, Princeton, NJ 08540

Daniel Chelsky

Pharmacopeia, Inc., 101 College Rd. East, Princeton, NJ 08540

Recent advances in combinatorial chemistry have resulted in the rapid screening of libraries against biological targets. Another advance in biological screening is the ability to design and utilize novel, automated, nonradioactive assays for targets of pharmaceutical interest. Using encoding technology and europium time-resolved fluorescence, we have designed primary receptor binding assays to define active compounds against the neurokinin-1 and neurokinin-2 receptor subtypes. In addition, a secondary, cell-based, functional assay measuring intracellular calcium flux with calcium sensitive fluorophores was used to determine receptor agonist or antagonist activities. We adapted a cuvette based assay to a CCD camera and digital imaging system that allowed us to demonstrate functional receptor antagonist activity in all 96 wells of a microtiter plate simultaneously. The screening of a 20,000 member library using europium labeled neurokinin ligands resulted in the identification of 43 active compounds for neurokinin-1 and 27 for neurokinin-2. Through medicinal chemistry and structure-activity relationships, a compound was synthesized with balanced dual antagonist activity at both neurokinin receptors with greater than 100-fold less activity against the neurokinin-3 receptor subtype. The structure-activity relationships generated from this initial library can now be used to design a new focused library to improve on neurokinin-1/neurokinin-2 receptor potency and selectivity.

Journal of Biomolecular Screening, Vol. 3, No. 1, 19-27 (1998)
DOI: 10.1177/108705719800300103


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. J. Mintzer, K. C. Appell, A. Cole, A. Johns, R. Pagila, M. A. Polokoff, I. Tabas, R. M. Snider, and J. A. Meurer-Ogden A Novel High-Throughput Screening Format to Identify Inhibitors of Secreted Acid Sphingomyelinase J Biomol Screen, April 1, 2005; 10(3): 225 - 234. [Abstract] [PDF]

				K. J. Valenzano, W. Miller, J. N. Kravitz, P. Samama, D. Fitzpatrick, and K. Seeley Development of a Fluorescent Ligand-Binding Assay Using the AcroWell Filter Plate J Biomol Screen, December 1, 2000; 5(6): 455 - 461. [Abstract] [PDF]

				J. Liu, M. Gallagher, R. A. Horlick, A. K. Robbins, and M. L. Webb A Time-Resolved Fluorometric Assay for Galanin Receptors J Biomol Screen, April 1, 1998; 3(3): 199 - 206. [Abstract] [PDF]